Home / Latest Reports / Polio Vaccines Market

Polio Vaccines Market By Product and End User - Global Industry Analysis And Forecast To 2027

Published On : June 2022 Pages : 150 Category: Pharmaceuticals Report Code : HC063905

Request Sample Inquiry Before Buying Request for Customization Check Discount

Polio Vaccines Market By Product (OPV and IPV) and End User (Public Services, Clinics, Hospital and Other End Users) - Global Industry Analysis And Forecast To 2027

Industry Outlook

The polio vaccines are the antibodies utilized for preventing the poliomyelitis (polio). Two kinds of the vaccine are utilized: the inactivated poliovirus provided by the injection (IPV) and the weakened poliovirus given through the mouth (OPV). Therefore, the Polio Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global Polio Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Drivers & Restrains

The factors driving the global market are; rising investment on the development of various types of the polio vaccines, rising number of effects across the globe for eradicating the polio disorder, increasing utilization in various economies and few other factors. The factors limiting the growth of market can be if any alternative for the treatment avaibale.

Regional Insights

The North American region is leading the global Polio Vaccines Market owing to factor like; increasing number of immunization drives taking place under the government, rising investment for the supply of this vaccine, technological development in the delivery systems, etc.

Polio Vaccines Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Serum Institute of India
  • Astellas Pharma
  • Sanofi
  • GlaxoSmithKline

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Polio Vaccines Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

o   OPV

o   IPV

o   Polio Vaccines Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Public Services

o   Clinics

o   Hospital

o   Other End Users

o   Polio Vaccines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o   Serum Institute of India

o   Astellas Pharma

o   Sanofi

o   GlaxoSmithKline

o   Polio Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Polio Vaccines Market , By Country

o   U.S. Polio Vaccines Market

o   Canada Polio Vaccines Market

o   Mexico Polio Vaccines Market

o   Europe

§  Europe Polio Vaccines Market , By Country

o   Germany Polio Vaccines Market

o   UK Polio Vaccines Market

o   France Polio Vaccines Market

o   Russia Polio Vaccines Market

o   Italy Polio Vaccines Market

o   Rest of Europe Polio Vaccines Market

o   Asia-Pacific

§  Asia-Pacific Polio Vaccines Market , By Country

o   China Polio Vaccines Market

o   Japan Polio Vaccines Market

o   South Korea  Polio Vaccines Market

o   India Polio Vaccines Market

o   Southeast Asia Polio Vaccines Market

o   Rest of Asia-Pacific Polio Vaccines Market

o   South America

§  South America Polio Vaccines Market , By Country

o   Brazil Polio Vaccines Market

o   Argentina Polio Vaccines Market

o   Columbia Polio Vaccines Market

o   Rest of South America Polio Vaccines Market

o   Middle East and Africa

§  Middle East and Africa Polio Vaccines Market , By Country

o   Saudi Arabia Polio Vaccines Market

o   UAE Polio Vaccines Market

o   Egypt Polio Vaccines Market

o   Nigeria Polio Vaccines Market

o   South Africa Polio Vaccines Market

o   Rest of MEA Polio Vaccines Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Polio Vaccines Market, By Product

5.1.     Introduction

5.2.     Global Polio Vaccines Revenue and Market Share by Product (2017-2027)

5.2.1.  Global Polio Vaccines Revenue and Revenue Share by Product (2017-2027)

5.3.     OPV

5.3.1.  Global OPV Revenue and Growth Rate (2017-2027)

5.4.     IPV

5.4.1.  Global IPV Revenue and Growth Rate (2017-2027)

6.       Polio Vaccines Market, By End User

6.1.     Introduction

6.2.     Global Polio Vaccines Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Polio Vaccines Revenue and Revenue Share by End User (2017-2027)

6.3.     Public Services

6.3.1.  Global Public Services Revenue and Growth Rate (2017-2027)

6.4.     Clinics

6.4.1.  Global Clinics Revenue and Growth Rate (2017-2027)

6.5.     Hospital

6.5.1.  Global Hospital Revenue and Growth Rate (2017-2027)

6.6.     Other End Users

6.6.1.  Global Other End Users Revenue and Growth Rate (2017-2027)

7.       Polio Vaccines Market, By Region

7.1.     Introduction

7.2.     Global Polio Vaccines Revenue and Market Share by Regions

7.2.1.  Global Polio Vaccines Revenue by Regions (2017-2027)

7.3.     North America Polio Vaccines by Countries

7.3.1.  North America Polio Vaccines Revenue and Growth Rate (2017-2027)

7.3.2.  North America Polio Vaccines Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Polio Vaccines by Countries

7.4.1.  Europe Polio Vaccines Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Polio Vaccines Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Polio Vaccines by Countries

7.5.1.  Asia-Pacific Polio Vaccines Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Polio Vaccines Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Polio Vaccines by Countries

7.6.1.  South America Polio Vaccines Revenue and Growth Rate (2017-2027)

7.6.2.  South America Polio Vaccines Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Polio Vaccines by Countries

7.7.1.  Middle East and Africa Polio Vaccines Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Polio Vaccines Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Serum Institute of India

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Astellas Pharma

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Sanofi

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     GlaxoSmithKline

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

9.       Polio Vaccines Market Forecast (2017-2027)

9.1.     Global Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Polio Vaccines Market Forecast by Regions (2017-2027)

9.2.1.  North America Polio Vaccines Market Forecast (2017-2027)

9.2.1.1.  United States Polio Vaccines Market Forecast (2017-2027)

9.2.1.2.  Canada Polio Vaccines Market Forecast (2017-2027)

9.2.1.3.  Mexico Polio Vaccines Market Forecast (2017-2027)

9.2.2.  Europe Polio Vaccines Market Forecast (2017-2027)

9.2.2.1.  Germany Polio Vaccines Market Forecast (2017-2027)

9.2.2.2.  France Polio Vaccines Market Forecast (2017-2027)

9.2.2.3.  UK Polio Vaccines Market Forecast (2017-2027)

9.2.2.4.  Russia Polio Vaccines Market Forecast (2017-2027)

9.2.2.5.  Italy Polio Vaccines Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Polio Vaccines Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Polio Vaccines Market Forecast (2017-2027)

9.2.3.1.  China Polio Vaccines Market Forecast (2017-2027)

9.2.3.2.  Japan Polio Vaccines Market Forecast (2017-2027)

9.2.3.3.  Korea Polio Vaccines Market Forecast (2017-2027)

9.2.3.4.  India Polio Vaccines Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Polio Vaccines Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Polio Vaccines Market Forecast (2017-2027)

9.2.4.  South America Polio Vaccines Market Forecast (2017-2027)

9.2.4.1.  Brazil Polio Vaccines Market Forecast (2017-2027)

9.2.4.2.  Argentina Polio Vaccines Market Forecast (2017-2027)

9.2.4.3.  Columbia Polio Vaccines Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Polio Vaccines Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Polio Vaccines Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Polio Vaccines Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Polio Vaccines Market Forecast (2017-2027)

9.2.5.3.  Egypt Polio Vaccines Market Forecast (2017-2027)

9.2.5.4.  Nigeria Polio Vaccines Market Forecast (2017-2027)

9.2.5.5.  South Africa Polio Vaccines Market Forecast (2017-2027)

9.2.5.6.  Turkey Polio Vaccines Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Polio Vaccines Market Forecast (2017-2027)

9.3.     Polio Vaccines Market Forecast by Product (2017-2027)

9.3.1.  Polio Vaccines Forecast by Product (2017-2027)

9.3.2.  Polio Vaccines Market Share Forecast by Product (2017-2027)

9.4.     Polio Vaccines Market Forecast by End User (2017-2027)

9.4.1.  Polio Vaccines Forecast by End User (2017-2027)

Polio Vaccines Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Polio Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Polio Vaccines Revenue and Revenue Share by Product (2017-2018)
Figure Global OPV Revenue and Growth Rate (2017-2018)
Figure Global IPV Revenue and Growth Rate (2017-2018)
Table Global Polio Vaccines Revenue and Revenue Share by End User (2017-2018)
Figure Global Public Services Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Other End Users Revenue and Growth Rate (2017-2018)
Table Global Polio Vaccines Revenue by Regions (2017-2018)
Figure North America Polio Vaccines Growth Rate (2017-2018)
Figure North America Polio Vaccines Revenue and Growth Rate (2017-2018)
Figure North America Polio Vaccines by Countries (2017-2018)
Figure North America Polio Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure United States Polio Vaccines Growth Rate (2017-2018)
Figure United States Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Polio Vaccines Growth Rate (2017-2018)
Figure Canada Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Polio Vaccines Growth Rate (2017-2018)
Figure Mexico Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Polio Vaccines Growth Rate (2017-2018)
Figure Europe Polio Vaccines Revenue and Growth Rate (2017-2018)
Figure Europe Polio Vaccines by Countries (2017-2018)
Figure Europe Polio Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Germany Polio Vaccines Growth Rate (2017-2018)
Figure Germany Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Polio Vaccines Growth Rate (2017-2018)
Figure France Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Polio Vaccines Growth Rate (2017-2018)
Figure UK Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Polio Vaccines Growth Rate (2017-2018)
Figure Russia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Polio Vaccines Growth Rate (2017-2018)
Figure Italy Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Polio Vaccines Growth Rate (2017-2018)
Figure Rest of Europe Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Polio Vaccines Growth Rate (2017-2018)
Figure Asia-Pacific Polio Vaccines Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Polio Vaccines by Countries (2017-2018)
Figure Asia-Pacific Polio Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure China Polio Vaccines Growth Rate (2017-2018)
Figure China Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Polio Vaccines Growth Rate (2017-2018)
Figure Japan Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Polio Vaccines Growth Rate (2017-2018)
Figure Korea Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Polio Vaccines Growth Rate (2017-2018)
Figure India Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Polio Vaccines Growth Rate (2017-2018)
Figure Southeast Asia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Polio Vaccines Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Polio Vaccines Growth Rate (2017-2018)
Figure South America Polio Vaccines Revenue and Growth Rate (2017-2018)
Figure South America Polio Vaccines by Countries (2017-2018)
Figure South America Polio Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Polio Vaccines Growth Rate (2017-2018)
Figure Brazil Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Polio Vaccines Growth Rate (2017-2018)
Figure Argentina Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Polio Vaccines Growth Rate (2017-2018)
Figure Columbia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Polio Vaccines Growth Rate (2017-2018)
Figure Rest of South America Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Polio Vaccines Growth Rate (2017-2018)
Figure Middle East and Africa Polio Vaccines Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Polio Vaccines by Countries (2017-2018)
Figure Middle East and Africa Polio Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Polio Vaccines Growth Rate (2017-2018)
Figure Saudi Arabia Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Polio Vaccines Growth Rate (2017-2018)
Figure United Arab Emirates Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Polio Vaccines Growth Rate (2017-2018)
Figure Egypt Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Polio Vaccines Growth Rate (2017-2018)
Figure Nigeria Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Polio Vaccines Growth Rate (2017-2018)
Figure South Africa Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Polio Vaccines Growth Rate (2017-2018)
Figure Turkey Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Polio Vaccines Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Polio Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Table Serum Institute of India Polio Vaccines Financial Overview
Table Astellas Pharma Polio Vaccines Financial Overview
Table Sanofi Polio Vaccines Financial Overview
Table GlaxoSmithKline Polio Vaccines Financial Overview
Figure Global Polio Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
Table Polio Vaccines Market Forecast by Regions (2018-2025)
Figure North America Polio Vaccines Market Forecast (2018-2025)
Figure United States Polio Vaccines Market Forecast (2018-2025)
Figure Canada Polio Vaccines Market Forecast (2018-2025)
Figure Mexico Polio Vaccines Market Forecast (2018-2025)
Figure Europe Polio Vaccines Market Forecast (2018-2025)
Figure Germany Polio Vaccines Market Forecast (2018-2025)
Figure France Polio Vaccines Market Forecast (2018-2025)
Figure UK Polio Vaccines Market Forecast (2018-2025)
Figure Russia Polio Vaccines Market Forecast (2018-2025)
Figure Italy Polio Vaccines Market Forecast (2018-2025)
Figure Rest of Europe Polio Vaccines Market Forecast (2018-2025)
Figure Asia-Pacific Polio Vaccines Market Forecast (2018-2025)
Figure China Polio Vaccines Market Forecast (2018-2025)
Figure Japan Polio Vaccines Market Forecast (2018-2025)
Figure Korea Polio Vaccines Market Forecast (2018-2025)
Figure India Polio Vaccines Market Forecast (2018-2025)
Figure Southeast Asia Polio Vaccines Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Polio Vaccines Market Forecast (2018-2025)
Figure South America Polio Vaccines Market Forecast (2018-2025)
Figure Brazil Polio Vaccines Market Forecast (2018-2025)
Figure Argentina Polio Vaccines Market Forecast (2018-2025)
Figure Columbia Polio Vaccines Market Forecast (2018-2025)
Figure Rest of South America Polio Vaccines Market Forecast (2018-2025)
Figure Middle East and Africa Polio Vaccines Market Forecast (2018-2025)
Figure Saudi Arabia Polio Vaccines Market Forecast (2018-2025)
Figure United Arab Emirates Polio Vaccines Market Forecast (2018-2025)
Figure Egypt Polio Vaccines Market Forecast (2018-2025)
Figure Nigeria Polio Vaccines Market Forecast (2018-2025)
Figure South Africa Polio Vaccines Market Forecast (2018-2025)
Figure Turkey Polio Vaccines Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Polio Vaccines Market Forecast (2018-2025)
Figure Global Polio Vaccines Forecast by Product (2018-2025)
Figure Global Polio Vaccines Market Share Forecast by Product (2018-2025)
Figure Global Polio Vaccines Forecast by Product (2018-2025)
Figure Global Polio Vaccines Forecast by End User (2018-2025)
Figure Global Polio Vaccines Market Share Forecast by End User (2018-2025)
Figure Global Polio Vaccines Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*